Fidia S.p.A. (FRA:FIC0)
Germany · Delayed Price · Currency is EUR | Market Cap | 15.49M +344.3% |
| Revenue (ttm) | 23.49M +7.6% |
| Net Income | -3.86M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,000 |
| Open | 0.0002 |
| Previous Close | 0.0010 |
| Day's Range | 0.0002 - 0.0002 |
| 52-Week Range | 0.0002 - 0.2230 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, production and sale of numerical controls and software, high-speed milling systems and after-sales technical assistance. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions incl... [Read more]
Financial Performance
Financial StatementsNews
BioMarin CEO Alexander Hardy: We're an at-scale leader in rare diseases
Alexander Hardy, BioMarin president and CEO, joins 'Squawk Box' to discuss the FDA's Rare Disease Framework Initiative, the company's rare disease targeted drug pipeline, the acquisition of Amicus The...
Phathom Defends VOQUEZNA Exclusivity As FDA Seeks Comments On Generic Drug Dispute; Stock Down
(RTTNews) - Phathom Pharmaceuticals, Inc. (PHAT) said Monday the U.S. Food and Drug Administration (FDA) opened a public docket seeking comments on legal and regulatory issues raised in BDR Pharmaceut...
Phathom Pharma To Intervene In Litigation Filed By BDR
(RTTNews) - Phathom Pharmaceuticals (PHAT) announced the FDA's establishment of a public docket to solicit comment on legal and regulatory questions regarding certain issues raised by a filer of an ab...
Coreline Soft Gets FDA 510(k) Clearance For AVIEW Aorta Metrics
(RTTNews) - Last Friday, Coreline Soft Co., Ltd. (384470.KQ) announced that it received U.S. FDA 510(k) clearance on October 16, 2026, for AVIEW Aorta Metrics, its AI-powered aortic quantitative analy...
Ascletis Submits U.S. IND For Oral Obesity Candidate ASC39
(RTTNews) - Ascletis Pharma Inc. (1672.HK, ASCLF.PK) announced the submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC39 oral tablets, an...
Food and Drug Administration (FDA) suspends 68 food licenses across Maharashtra
FDA Maharashtra suspends 68 food licences in festive drive; Rs 12.7 crore stock seized for hygiene violations, adulteration, expired goods and gutka.
After a long, strange trip, this CEO is close to taking a psilocybin pill to market
Compass Pathways is on the cusp of FDA approval for a proprietary version of psilocybin — the active drug in magic mushrooms.
Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approval
5 Space Stocks That Could Soar in the Next DecadeOpus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal di...
Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy
Exelixis will have to wait longer than expected to earn approval for a new drug. It's not the end of the world.
AbbVie Gains FDA Approval For Subcutaneous Induction Of SKYRIZI In Crohn's Disease
(RTTNews) - AbbVie (ABBV) announced that the U.S. Food and Drug Administration approved a subcutaneous induction regimen for SKYRIZI (risankizumab-rzaa) for adults with moderately to severely active C...
Kennedy rolls out US-caught seafood labeling, Seafood.gov
The Trump administration unveiled new initiatives for U.S. fishermen Friday, including a new government website known as Seafood.gov. At a rally in Fort Myers, Fla., Health and Human Services (HHS) Se...
Phathom Pharmaceuticals (PHAT) Shares Drop 18% Amid FDA Lawsuit Over Voquezna Generic Application
Phathom Pharmaceuticals (PHAT) Shares Drop 18% Amid FDA Lawsuit Over Voquezna Generic Application
AbbVie (ABBV) Gains FDA Nod for At-Home Skyrizi Induction in Crohn's Disease
AbbVie (ABBV) Gains FDA Nod for At-Home Skyrizi Induction in Crohn's Disease
NRX Pharmaceuticals (NRXP) Highlights NYT Correction on FDA Petition Over Ketamine Preservative
NRX Pharmaceuticals (NRXP) Highlights NYT Correction on FDA Petition Over Ketamine Preservative
FDA Approves Awiqli for Pediatric Type 2 Diabetes, Boosting Novo Nordisk (NVO) Growth Prospects
FDA Approves Awiqli for Pediatric Type 2 Diabetes, Boosting Novo Nordisk (NVO) Growth Prospects
BDR Pharmaceuticals Sues FDA Over Voquezna Application, Impacting PHAT Stock
BDR Pharmaceuticals Sues FDA Over Voquezna Application, Impacting PHAT Stock
FDA suspends licences of 2 establishments in Mumbai
FDA Maharashtra suspended licences of two Mumbai food establishments after hygiene violations; raids statewide seized 33 tonnes of food stock worth Rs 65.8 lakh.
Colgate’s whitening toothpaste is 47% off today, and it’s not on the FDA’s recall list
Colgate isn’t on the FDA’s list of recalled toothpastes, and one of its popular whitening formulas is 47% off. Get a pack of three for under $3 per tube.
BDR Pharmaceuticals Sues FDA Over Voquezna Exclusivity, Impacting Phathom Pharmaceuticals (PHAT)
BDR Pharmaceuticals Sues FDA Over Voquezna Exclusivity, Impacting Phathom Pharmaceuticals (PHAT)
Phathom Pharmaceuticals Reports BDR Lawsuit Challenging VOQUEZNA Exclusivity
(RTTNews) - Phathom Pharmaceuticals (PHAT) announced that BDR Pharmaceuticals International Pvt. Ltd. has filed a lawsuit against the U.S. Food and Drug Administration (FDA) and related federal defend...
Cardiff's Onvansertib Wins FDA Orphan Drug Designation For Rare Blood Cancer
(RTTNews) - Cardiff Oncology, Inc. (CRDF) on Wednesday said the U.S. Food and Drug Administration granted orphan drug designation to Onvansertib for chronic myelomonocytic leukemia.
Phathom Says BDR Pharmaceuticals Sues FDA Over VOQUEZNA Exclusivity
(RTTNews) - Biopharmaceutical company Phathom Pharmaceuticals, Inc. (PHAT) announced on Friday that Mumbai, India-based BDR Pharmaceuticals International Pvt. Ltd. has filed a lawsuit against the U.S....
FDA Lifts Clinical Hold On Aardvark's ARD-101 For Prader-Willi Syndrome; Stock Up 16%
(RTTNews) - On Thursday, Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company, said that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on ARD-101 f...
Labcorp (LH) Partners with FDA and Charles River to Advance Drug Abuse Assessment Methods
Labcorp (LH) Partners with FDA and Charles River to Advance Drug Abuse Assessment Methods
Charles River Laboratories (CRL) Partners with FDA and Labcorp to Advance Drug Abuse Screening Tools
Charles River Laboratories (CRL) Partners with FDA and Labcorp to Advance Drug Abuse Screening Tools